Organon OGN
NYSE OGN
$13.72 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Organon (OGN) Income from Discontinued Operations (2020 - 2021)

Updated

Organon (OGN) reported Income from Discontinued Operations of -$4 million for Q2 2021, compared with -$44 million a year earlier.

Analysis

Organon (OGN) Income from Discontinued Operations (2020 - 2021) Analysis & Trends

For FY2020, Organon posted Income from Discontinued Operations of -$96 million.

  • By year, Income from Discontinued Operations came in at -$88 million in FY2019.
  • Five-year quarterly Income from Discontinued Operations spans a low of -$44 million in Q2 2020 and a high of $4 million in Q1 2021.
  • Per Business Quant data, the three quarters before Q2 2021 came in at $4 million (Q1 2021), -$8 million (Q4 2020) and -$13 million (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Organon 3.60 Bn 109.00 Mn 847.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -4.00 Mn
Mar 31, 2021 4.00 Mn
Dec 31, 2020 -8.00 Mn
Sep 30, 2020 -13.00 Mn
Jun 30, 2020 -44.00 Mn
Mar 31, 2020 -31.00 Mn
API Access

Organon Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=OGN&period=max&api_key=YOUR_API_KEY